<p>Mice were immunized by soluble TT alone (i/m), TT with alum (i/m) or TT via HET. Unimmunized animal served as control. Booster of soluble TT (i/m) was given on Day 28 and mice were bled on week 5. Serum anti TT IgG1 (A1), IgG2a (A2) and IgG (A3) were estimated by ELISA. Recall response was evaluated by estimating the proliferative index by <i>in vitro</i> restimulation of splenocytes from immunized animals with TT antigen (B). Each dot represents individual animal and bars represent the geometric mean of each group.</p
<p><i>Mcph1<sup>tm1a/tm1a</sup></i> and <i>Mchp1<sup>+/+</sup></i> mice were immunised intranasally ...
<p>(A) VNNESSE-variants, (B) FIGITEL-variants, (C) SYFPSV-variants and (D) PNRDIL-variants. Control ...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>Serum samples were collected two weeks after the completion of the immunizations and were assayed...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>The immunization protocol is represented in the inset schema. (A) Antisera collected 14 days afte...
<p>Mice were administered PBS (Control), ITIV (0.5 μg A/H1N, A/H3N2, and B HA/mouse; Vaccine), ITIV ...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
<p>Serum samples were obtained before the first (Pre) and 15 days after the last dose (Post) of immu...
<p>Panel A, antibody titers of mice primed with Construct 33-I and boosted with MSP1-42; and antibod...
<p>Wild type and Tbet-/- mice were infected intranasally with RV1B or sham infected with PBS. Blood ...
<p>Panel A: anti-LT IgG and IgA antibody titers from serum and intestine wash samples of the IP immu...
<p>(A) Two independent lots of commercially available antisera each representing pooled antisera fro...
<p><i>Mcph1<sup>tm1a/tm1a</sup></i> and <i>Mchp1<sup>+/+</sup></i> mice were immunised intranasally ...
<p>(A) VNNESSE-variants, (B) FIGITEL-variants, (C) SYFPSV-variants and (D) PNRDIL-variants. Control ...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>Groups of three to four mice each were vaccinated at days 0, 14, 28 and 126 (downward pointing op...
<p>Serum samples were collected two weeks after the completion of the immunizations and were assayed...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>The immunization protocol is represented in the inset schema. (A) Antisera collected 14 days afte...
<p>Mice were administered PBS (Control), ITIV (0.5 μg A/H1N, A/H3N2, and B HA/mouse; Vaccine), ITIV ...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
<p>Serum samples were obtained before the first (Pre) and 15 days after the last dose (Post) of immu...
<p>Panel A, antibody titers of mice primed with Construct 33-I and boosted with MSP1-42; and antibod...
<p>Wild type and Tbet-/- mice were infected intranasally with RV1B or sham infected with PBS. Blood ...
<p>Panel A: anti-LT IgG and IgA antibody titers from serum and intestine wash samples of the IP immu...
<p>(A) Two independent lots of commercially available antisera each representing pooled antisera fro...
<p><i>Mcph1<sup>tm1a/tm1a</sup></i> and <i>Mchp1<sup>+/+</sup></i> mice were immunised intranasally ...
<p>(A) VNNESSE-variants, (B) FIGITEL-variants, (C) SYFPSV-variants and (D) PNRDIL-variants. Control ...
<p>(A) Mice (n = 8/group) were immunized once with TVV+MM or PBS as negative control 4 weeks before ...